Overview
Amanda Redig is an Oncologist practicing medicine in Boston, Massachusetts. She has been practicing medicine for over 16 years.
Dr. Redig is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Lung Adenocarcinoma.
She is actively involved in clinical research, co-authoring 29 peer reviewed articles and participating in 2 clinical trials.
Graduate Year
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
450 Brookline Ave, Boston, MA 02215
75 Francis St, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Dana-Farber Cancer Institute
Matthew Davids is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Davids is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Dana-Farber Cancer Institute
Eric Jacobsen is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Jacobsen is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Dana-Farber Cancer Institute
Daniel Deangelo is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Deangelo is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Systemic Mastocytosis, Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Frequently Asked Questions about Dr. Amanda Redig
How do I make an appointment with Dr. Amanda Redig?
You can book an appointment with Dr. Amanda Redig by calling their office at 617-632-3779. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Amanda Redig a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Amanda Redig is classified as an Advanced expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Amanda Redig specialize in?
While Dr. Amanda Redig is a Oncology, they have specific expertise in Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and EGFR Positive Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Amanda Redig participate in research or clinical trials?
Yes. Dr. Amanda Redig has published 29 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Dr. Amanda Redig's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EGFR Positive Lung CancerDr. Redig isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung CancerDr. Redig isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- Large-Cell Lung CarcinomaDr. Redig isExperienced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Redig isExperienced. Learn about Lung Adenocarcinoma.
- MesotheliomaDr. Redig isExperienced. Learn about Mesothelioma.
- Pleuropulmonary BlastomaDr. Redig isExperienced. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Redig isExperienced. Learn about Small Cell Lung Cancer (SCLC).